Search

Your search keyword '"Cadavid, Diego"' showing total 535 results

Search Constraints

Start Over You searched for: Author "Cadavid, Diego" Remove constraint Author: "Cadavid, Diego"
535 results on '"Cadavid, Diego"'

Search Results

1. Social communication in fragile X syndrome: pilot examination of the Brief Observation of Social Communication Change (BOSCC)

2. Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial

3. FMRP Levels in Human Peripheral Blood Leukocytes Correlates with Intellectual Disability.

5. Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities.

7. Omnichannel diagnosis for micro, small and medium-sized companies, sectorial study.

9. Interplay of Customer Satisfaction, Innovation, and Product Quality: Key Determinants of Company Performance

10. Interrelations between logistics, trade, and law in the Incoterms® context

11. Bounce-back strategies: Revitalizing the hotel industry post-pandemic

15. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

20. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

29. Mavorixafor for Patients with Chronic Neutropenic Disorders: Results from a Phase 1b, Open-Label, Multicenter Study

32. Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI

33. Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole‐body fat‐referenced MRI : Protocol development, multicenter feasibility, and repeatability

35. Factores económicos e incidencia en las exportaciones agrícolas: Caso de Colombia comparado ante diferentes países

36. Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI Composite Scores for Longitudinal and Cross-sectional Analysis

37. Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole-body fat-referenced MRI: Protocol development, multicenter feasibility, and repeatability

38. Quantitative muscle analysis in FSHD using Whole-Body MRI: Composite Muscle Measurements for Cross-Sectional Analysis (P12-13.001)

39. An Open-Label Study of Losmapimod to Evaluate the Safety, Tolerability, and Biomarker and Clinical Outcome Assessment Changes in Subjects with FSHD1 (S23.008)

40. A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 48-Week Study of the Efficacy and Safety of Losmapimod in Subjects with FSHD: ReDUX4 (S23.007)

41. Whole Body MRI Quantitative muscle analysis to evaluate Efficacy of Losmapimod in a Phase 2 Placebo-Controlled Study in Subjects with FSHD (ReDUX4) (S23.009)

42. Trapped guidewire during coronary sinus electrode exchange in cardiac resynchronization therapy

47. Preliminary Clinical Response Data from a Phase 1b Study of Mavorixafor in Combination with Ibrutinib in Patients with Waldenström's Macroglobulinemia with MYD88 and CXCR4 Mutations

48. Oral Administration of Mavorixafor, a CXCR4 Antagonist, Increases Peripheral White Blood Cell Counts across Different Disease States

50. Global Phase 3, Randomized, Placebo-Controlled Trial with Open-Label Extension Evaluating the Oral CXCR4 Antagonist Mavorixafor in Patients with WHIM Syndrome (4WHIM): Trial Design and Enrollment

Catalog

Books, media, physical & digital resources